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Background/aim: The aim of this study was to investigate the effects of conscious sedation with 40% nitrous oxide/oxygen (N2O/O2)
on cognitive functions.
Materials and methods: Forty dental patients referred to the sedation unit at Gazi University Faculty of Dentistry Department of Oral
and Maxillofacial Surgery received a combination of 40% N2O/O2 inhalation for conscious sedation. Psychometric tests were applied
three times: before sedation, during sedation, and at the end of the recovery, for assessing cognitive functions.
Results: The results of this study showed that the 40% N2O/O2 combination impaired cognitive functions during the conscious sedation.
Recovery of most of the cognitive functions occurred 15 min after sedation. However, in addition to the persistence of ‘hypnotic effects’
and ‘sensations of isolation’ during the recovery period, ‘motor loss value’ showed more cognitive impairment 15 min after sedation than
before the sedation period, and, thus, the ability to execute fine motor skills was not totally recovered by then.
Conclusion: The results of this study could be crucial for informing patients about avoiding attentive activities soon after conscious
sedation via 40% N2O/O2.
Key words: Cognitive symptoms, conscious sedation, nitrous oxide

1. Introduction
Conscious sedation is defined as ‘a technique in which the
use of a drug or drugs produces a state of depression of the
central nervous system enabling treatment to be carried
out, but during which verbal contact with the patient
is maintained throughout the period of sedation’ (1).
Inhalation sedation using nitrous oxide/oxygen (N2O/O2)
is one of the standard techniques for achieving conscious
sedation (2).
Utilization of N2O for conscious sedation is a
widespread approach owing to its acceptable cardiovascular
effects and the technique’s several advantages at clinical
concentrations (3,4). N2O is a nonflammable, colorless,
and virtually odorless gas with a faint, sweet smell (5).
It provides a rapid onset of sedation with short duration
of action and early recovery. The level of sedation can be
easily altered or discontinued (6).
Conscious sedation via N2O/O2 is a reliable,
efficient, and safe adjunct to local anesthesia for patients
undergoing ambulatory oral surgery procedures and
can be administrated safely and effectively by trained
* Correspondence: sara_samur@hotmail.com

dental practitioners (7–9). However, the use of N2O has
not always been unproblematic or without controversy
(10,11). Despite the widespread clinical use, nitrous oxide’s
cognitive effects are not completely understood. The aim
of this study was to investigate the effects of conscious
sedation via 40% N2O/O2 on cognitive functions in
consideration of the recovery time and side effects.
2. Materials and methods
2.1. Patients
This study was approved by the local institutional review
board (Ankara University Faculty of Medicine, Board
of Assessment of Clinical Studies) and the General
Directorate of Pharmaceuticals and Pharmacy of the
Republic of Turkey’s Ministry of Health. It was performed
in accordance with the guidelines of the Declaration
of Helsinki. The study included 40 healthy adult dental
patients aged 22 to 31. All were classified as ASA I patients
and showed a moderate level of anxiety (determined by
Corah Dental Anxiety Scale) towards dental treatment
(12,13). The patients were enrolled in the study after
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signing their written informed consent. Patients with a
medical contraindication to the use of N2O (persistence
of closed/air-filled cavity, reduced consciousness of any
origin, pregnancy, conditions making the application
of the nasal mask difficult) were excluded. Sedation
applications and cognitive assessments were performed by
the same researchers.
2.2. Materials
The subjects received a 40% N2O/O2 combination
inhalation via nasal mask for conscious sedation (AMS
Relaxodent AMS Ltd, Ankara, Turkey). Vital functions
that include systolic blood pressure (SBP), diastolic blood
pressure (DBP), pulse rate (PR), and peripheral saturation
of oxygen (SpO2) values were monitored throughout the
procedure. Psychometric tests that originated from the
digit span subtest (DSS), digit symbol coding test (DSCT),
Nelson hand reaction test (NHRT), and finger tapping
test (FTT) were applied three times: before sedation (T0),
during sedation (T1), and at the end of the recovery (T2) for
assessing cognitive functions. Three different test formats
with the same difficulty level were constituted for the DSS
and DSCT with the aim of prohibiting a memorizing effect.
Digit span subtest: This test serves to measure the
subject’s attention and working memory whereby the
subject has to memorize and articulate increasing lengths
of sequences of numbers read aloud by the experimenter
in a specific order, i.e. in both the same and reverse
order. Each sequence involves two trials; each correct
response is awarded one point. High scores indicate better
performances (14,15).
Digit symbol coding test: This is one of the oldest and
best established psychological tests that assesses visual
acuity, motor coordination and, speed (15). In this test,
digits from 1 to 9 were each assigned a respective symbol,
which the subjects had to match. Then they were given
a series of random digits next to which the subjects had
to write the corresponding symbols within 90 s (16). For
the current protocol 2 min are given for testing time.
During the data assessment for DSCT, symbols that were
coded formless and untidy by subjects were considered an
indication of the impairment of fine motor functions and
termed as ‘motor loss value’.
Nelson hand reaction test: In this measure of motor
coordination and reaction time, the subject is asked to
grab a ruler that contains numbers on its surface. Subjects
must put their hand on the appropriate position and must
use their thumb and index finger to grab the ruler. The
number between the fingers represents the score. Low
scores indicate better performances (17). For the current
protocol 10 trials with the dominant hand were recorded.
Finger tapping test: In order to test fine motor speed,
subjects are to tap a lever with the index finger of each
hand, in 10-s intervals. The test records how many times
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the subjects can fulfill this task. For the current protocol
five trials with the dominant hand were recorded (14,18).
2.3. Procedure
The patients were instructed not to consume food or
drink 4 h before the procedure. Consumption of caffeinecontaining drinks was restricted to only one cup of tea
or coffee at breakfast on the test day. Tobacco was not
permitted 2 h before the onset of the procedures on the
test day. The subjects were instructed not to consume any
alcohol or medication before the start of the test session
until the end of the session.
Vital functions that include SBP, DBP, PR, and SpO2
values were monitored throughout the session and
recorded at the time T0, T1, T2, and before discharge of
patient (T3). The level of consciousness, color of skin, and
subjective and side effects experienced by subjects were
evaluated. Hemodynamic values and side effects were
recorded at the time T0, T1, T2, and T3.
The subjects were settled in a dental chair in the
sedation room. Psychometric tests were performed and
baseline cognitive values were obtained (T0). The nasal
mask was attached to the patient and the machine adjusted
to administer 100% O2 at an appropriate flow rate (5 L/m).
Three minutes later, the subjects were given 10% N2O and
were informed that they may experience light-headedness,
tingling of the hands and feet, suffusion of warmth, and
changes in visual or auditory sensation (19). The N2O level
was increased gradually (10% per min) up to a level of
40% N2O and 60% O2. The N2O level was maintained at
40% (5 L/m). Verbal contact was maintained all the time
to maintain the subjects’ confidence and cooperation.
The cognitive assessment did not begin until 3 min of
continuous inhalation of 40% N2O. Psychometric tests
were performed at the end of this time (T1), and cognitive
values during the sedation period were obtained. After
the completion of the cognitive assessment, N2O flow was
turned off incrementally, and 100% O2 was administered for
3 min before the nasal mask was removed. Fifteen minutes
after mask removal, psychometric tests were applied a third
time (T2) and cognitive values representing the estimated
recovery time were obtained. Sedation procedures were
accomplished in all cases without encountering any
serious complications. The whole planned procedure took
approximately 40 minutes to perform for each subject.
After the completion of the procedure, subjects were
observed for 30 minutes and subsequently, they were
discharged with postoperative instructions.
2.4. Statistical analyses
Statistical analyses were performed with SPSS Version 17.0
(SPSS Inc., Chicago, IL, USA). The results are presented
as mean, standard deviation, minimum–maximum, and
number [mean ± SD, (min–max), n (%)]. P-values < 0.05
were considered statistically significant.
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The Kolmogorov–Smirnov test was used to evaluate
distributions of measurable parameters. Intergroup
statistical analyses were performed using one-way ANOVA
and Tukey’s test. Side effects and DSCT - motor loss values
were analyzed using the chi-squared test or Fisher’s exact
chi-squared test.
3. Results
The characteristics of the subjects are presented in Table 1.
Hemodynamic parameters that include SBP, DBP, PR, and
SpO2 are shown in Table 2. SBP was significantly higher
(P = 0.005) during the sedation period compared to the
baseline. Other hemodynamic parameters were similar.
The effects of N2O on cognitive performance are
presented in Table 3. Cognitive performance was impaired
significantly at T1 compared to T0 for both tests (P < 0.0001).
Cognitive values at T2 (15 min after cessation of N2O)

indicated a high level of cognitive functions compared
with T0 and were statistically significant for DSCT, NHRT,
and FTT (P values respectively: P = 0.001, P = 0.002, P =
0.019). Motor loss values in the DSCT are shown in Table
4. Motor loss values showed more cognitive impairment at
T1 and T2 compared with T0 (P < 0.0001).
Side effects that occurred during the sessions were
divided into 14 groups (Table 5). Side effects including
hypnotic effects, sensation of isolation, euphoric
effects, perioral numbness, tinnitus, and dizziness
were significantly high during the sedation period (T1)
compared with the baseline period (T0) (respectively P <
0.0001, P < 0.0001, P < 0.0001, P < 0.0001, P = 0.005, P <
0.0001). Hypnotic effects and sensation of isolation were
still significantly high during the recovery period (T2)
compared with the baseline period (T0) (respectively P =
0.001, P < 0.0001).

Table 1. Subject’s characteristics.
Age (years)

25.15 ± 2.17 (22–31)

Sex (male/female)

20/20

Body weight (kg)

68.10 ± 14.60 (46–110)

Height (cm)

172.03 ± 9.99 (155–193)

BMI

22.75 ± 2.84 (18.3–32.5)

Duration of sedation procedure (min)

23.30 ± 3.81 (17–35)

Data are presented as mean ± SD (min–max) or number of subjects
BMI, body mass index

Table 2. Time-dependent hemodynamic parameters of the patients.
T0
(n = 40)

T1
(n = 40)

T2
(n = 40)

T3
(n = 40)

**P

SBP
(mmHg)

116.98 ± 11.00
(95–140)

120.93 ± 10.85*
(94–148)

116.85 ± 8.79
(101–137)

117.28 ± 10.06
(98–137)

0.049

DBP
(mmHg)

77.13 ± 6.45
(64–91)

76.98 ± 9.79
(55–96)

77.70 ± 8.47
(55–94)

77.23 ± 8.40
(59–101)

0.982

PR
(pulse/min)

77.05 ± 8.21
(58–94)

76.18 ± 9.85
(52–103)

75.63 ± 9.02
(56–97)

74.83 ± 8.90
(58–98)

0.731

SpO2

98.58 ± 0.68
(97–99)

98.78 ± 0.62
(96–99)

98.65 ± 0.58
(97–99)

98.58 ± 0.64
(97–99)

0.442

Data are presented as mean ± SD (min–max)
**P < 0.05 Multiple comparison (one-way ANOVA)
*P < 0.05 Compared with baseline
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Table 3. The effects of N2O on cognitive performance measures.
T0 (n = 40)

T1 (n = 40)

T2 (n = 40)

**P

DSS

17.95 ± 4.30 (11–27)

15.03 ± 4.14* (9–24)

18.78 ± 3.71& (12–26)

P < 0.0001

DSCT

77.23 ± 13.39 (49–106)

68.48 ± 13.50* (36–95)

81.33 ± 12.70*,& (45–113)

P < 0.0001

NHRT

13.78 ± 2.77 (7.30–18.40)

16.99 ± 4.64* (4.70–26.90)

12.55 ± 2.43*,& (5.30–17.50)

P < 0.0001

FTT

350.30 ± 48.80 (246–466)

331.78 ± 48.67* (237–502)

361.85 ± 53.10*,& (280–551)

P = 0.029

Data are presented as mean ± SD (min–max)
**P < 0.05 Multiple comparison (one-way ANOVA)
*P < 0.05, Compared with T0
&P < 0.05, Compared with T1

Table 4. Motor loss values in DSCT.
T0 (n = 40)

T1 (n = 40)

T2 (n = 40)

0

27 (67.5)

7 (17.5)

7 (17.5)

1

10 (25)

7 (17.5)

6 (15)

2

-

4 (10)

9 (22.5)

3

-

6 (15)

4 (10)

4

2 (5)

6 (15)

4 (10)

5

-

3 (7.5)

1 (2.5)

6

1 (2.5)

3 (7.5)

2 (5)

7

-

3 (7.5)

4 (10)

8

-

1 (2.5)

2 (5)

9

-

-

-

10

-

-

-

11

-

-

1 (2.5)

**P

χ2 = 49.842
P < 0.0001

Data presented as [n (%)]
**P < 0.05 Multiple comparison (chi-squared or Fisher’s exact chi-squared)

4. Discussion
It is well documented that N2O at the dosages routinely used
for dental procedures affects cognitive functions such as
psychomotor performances, attention, memory, reaction
time, and facial recognition tasks (20–23). The common
impression is that N2O at analgesic dosage levels such as
in routine dental procedures acutely impairs cognitive
functions, but within 5 min most of these functions were
recovered completely, and by 20 min all of them (22).
For dental outpatients undergoing conscious sedation,
recovery from sedation must be sufficient to allow a safe
discharge home (24). As a general approach, after 10–15
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min following the N2O/O2 sedation the patient is usually
fit to be discharged (6). We hypothesized that cognitive
impairment could persist for 15 min after conscious
sedation via 40% N2O/O2 inhalation. We aim to reconsider
discharge requirements and instructions for patients after
N2O sedation.
Armstrong et al. (21) reported that 15% N2O impairs
attention and psychomotor performance. Thompson et al.
(25) reported that 25% N2O does not significantly impair
higher cognitive tasks, and, thus, patients can resume
normal activities in the postoperative period and so there
is no need for an escort to accompany them.
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Table 5. Side effects.
T0 (n = 40)

T1 (n = 40)

T2 (n = 40)

T3 (n = 40)

**P

Euphoric effects

0/40

34 (85)/6(15)*

2 (5)/38(95)

0/40

χ2 = 115.090
P < 0.0001

Hypnotic effects

0/40

13 (32.5)/27(67.5)*

10 (25)/29(75)*

2(5)/38(95)

χ2 = 22.139
P < 0.0001

Sensation of isolation

0/40

38 (95)/2(5)*

11 (27.5)/29(72.5)*

3(7.5)/37(92.5)

χ2=93.207
P < 0.0001

Perioral numbness

0/40

18 (45)/22(55)*

3 (7.5)/37(92.5)

0/40

χ2 = 48.839
P < 0.0001

Tinnitus

0/40

8 (20)/32(80)*

0/40

0/40

χ2 = 25.263
P < 0.0001

Rise of pressure in ear

0/40

3(7.5)/37(92.5)

0/40

0/40

χ2 = 6.747
P = 0.080

Subjective effects related to
attention/perceive

0/40

4 (10)/36(90)

0/40

1(2.5)/39(97.5)

χ2 = 8.870
P = 0.065

Mild headache

0/40

1(2.5)/39(97.5)

2(5)/38(95)

2(5)/38(95)

χ2 = 2.271
P = 0.518

Dizziness

0/40

12 (30)/28(70)*

0/40

0/40

χ2 = 38.919
P < 0.0001

Objective symptoms (slowing of
conversation, reducing of eye movements)

0/40

4 (10)/36(90)

0/40

0/40

χ2 = 8.492
P = 0.055

Palpitation

0/40

2 (5)/38(95)

0/40

0/40

χ2 = 5.522
P = 0.132

Nausea

0/40

2 (5)/38(95)

2(5)/38(95)

2(5)/38(95)

χ2 = 2.078
P = 0.556

Being cold

0/40

0/40

3(7.5)/37(92.5)

0/40

χ2 = 6.747
P = 0.080

Other symptoms

0/40

3(7.5)/37(92.5)

0/40

1(2.5)/39(97.5)

χ2 = 6.154
P = 0.104

Data are presented as [n (%)]
**P < 0.05 Multiple comparison (chi-square or Fisher’s exact chi-square)
*P < 0.05 Comparing with baseline

N2O had a significant effect on reaction time and facial
recognition tasks at dosages ranging from 30% to 55%
in a previous study (22). Zacny et al. (26) reported that
psychomotor recovery from N2O was rapid and completed
5 min after the inhalation period. Ayer and Getter (27)
reported that psychomotor impairment accruing from
the use of N2O (range from 35% to 40%) during dental
treatment was completely recovered after 20 min.
Lichtor et al. (28) reported that during 20% and 40%
N2O inhalation subjects had mood and psychomotor
effects based on the questionnaire, visual analogue scale,
and psychomotor tests. One hour after the cessation
of inhalation, these effects were not significant. Their
study suggests that the long-term effects of N2O are not

significant, and after 1 h there is no evidence for abstaining
from normal activities.
The results of this study showed that a 40% N2O/
O2 combination impaired cognitive functions during
conscious sedation; however, the recovery of most of the
cognitive functions occurred 15 min after sedation. In
the meantime, motor loss value was indicated by coding
symbols formless and untidy in the DSCT; the result of
this value showed more cognitive impairment 15 min after
sedation than before the sedation period. Thus, the ability
to execute fine motor skills was not totally recovered at this
time. Side effects including hypnotic effects and sensation
of isolation continue 15 min after sedation, supporting the
findings of loss of ability to perform fine motor skills.
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The result of this study could be crucial for giving
information to the patients about avoiding attentive
activities soon after conscious sedation via N2O/O2. In our
opinion, written postoperative instructions that indicate
avoiding tasks that require attention, precision, and fine
motor skills after N2O sedation should be mandatory.
In many areas of medical services 40% N2O has been
used with a great degree of safety (28). In dental practice,
criteria such as the patient’s sensitivity to the agent and
the clinician’s expectation of the sedation could cause
remarkable variations, but the average concentration
of N2O needed for conscious sedation is 40% (29). In
consideration of previous studies, we performed sedation
sessions at the ratio of 40% N2O to 60% O2.
Faulks et al. (30) reported that sedation with 50%
N2O/O2 for outpatient dental treatment of patients with
intellectual disability was safe and effective; during 605
sedation sessions no serious side effects were observed
and minor side effects (such as nausea, vomiting, sweating,
headache) occurred in 10.1% of the sessions. In terms of
a 10-year retrospective study, it has been reported that
the use of N2O/O2 sedation provides reliable conscious
sedation in the pediatric outpatient population; the nausea
and vomiting rate was 1.5% (4).
Hennequin et al. (8) reported remarkable treatment
success, patient cooperation, dentist satisfaction, and rare
minor side effects in conscious sedation by using 50% N2O
in O2 (Kalinox) by trained dental practitioners. The most
frequently reported side effects were behavioral (euphoria,

hyperexcitability), vagal (sweating, pallor, vertigo), and
digestive disorders (nausea, vomiting) respectively in
5.3%, 4.4%, and 2.8% of the sessions. In consideration
of the technique’s safety and effectiveness, the authors
recommended using it in complex dental treatments such
as oral surgery. Abdullah et al. (31) reported side effects
during sedation with N2O/O2: dizziness, paraesthesia of
fingers, nausea, bradycardia, and headache respectively
in 20%, 20%, 10%, 10%, and 5% of cases. Another review
article reported that minor side effects such as nausea and
vomiting occur in 4%–10% of cases (32).
In the present study, side effects that include hypnotic
effects, sensation of isolation, euphoric effects, perioral
numbness, tinnitus, and dizziness were significantly high
during the sedation period compared with the period
before sedation. Hypnotic effects and sensation of isolation
were still significantly high during the recovery period.
Nausea was determined during the sedation period and
recovery period and before discharge in 5% of cases. That
result was not statistically significant. Vomiting was not
monitored in any case.
The data presented in this study only apply to N2O given
alone. Further studies are warranted for patients who have
inhaled N2O for longer periods or included the concurrent
use of other sedative agents. Studies that include tests
with high sensitivity and selectivity that assess cognitive
functions and fine motor skills over a longer period after
recovery time would be beneficial.
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